Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with lower urinary tract symptoms also have undiagnosed erectile dysfunction, which improves with treatment.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Finasteride is a safe and effective long-term treatment for prostate enlargement, reducing prostate volume and related symptoms.

Finasteride may cause breast enlargement, low testosterone a risk factor.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

BPH treatments are improving with personalized medicine and better surgical options.

Combining TUSV with finasteride effectively treats recurrent hemospermia.

Phellodendri Cortex Extract may help treat enlarged prostate.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

For better medication adherence in benign prostatic hyperplasia treatment, tamsulosin and finasteride should be packaged together and taken at the same time.

Many patients with benign prostatic hyperplasia experience high anxiety and residual symptoms, needing better anxiety management.

Researchers found four natural compounds that can change DHT levels in prostate cancer cells.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

Large prostate patients more likely to have hair loss.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Finasteride reduces prostate size and symptoms with few side effects.

Dutasteride may help shrink prostate cancer tumors.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Using tamsulosin and finasteride together for benign prostatic syndrome has increased and shows improvement in symptoms, but more reliable comparisons are needed.